2 hours ago
1
TBE/iStock Editorial via Getty Images
- A federal court in Delaware on Friday ruled that MSN Pharmaceuticals has not infringed a patent related to Novartis’ (NYSE:NVS) heart failure therapy Entresto, in its marketing application aimed at introducing a generic version of the blockbuster drug in the
English (US) ·